关于2022年关于集群头痛临床试验设计指南的评论以及进一步的建议
Ioana Medrea1, Stewart J Tepper2, Donliang Wang3
1SUNY Upstate Medical University, Syracuse, New York, USA. medreai@upstate.edu.
The journal of headache and pain
|March 8, 2024
概括
讨论了新的集群头痛试验指导方针,建议进行非劣势试验,以解决伦理问题,并改善为更有效的临床研究招聘.
科学领域:
- 神经学 神经学
- 临床试验设计 临床试验设计
- 头痛 医学 医学 医学
背景情况:
- 最近发布的指南旨在标准化集群头痛临床试验.
- 本研究提供了加强试验方法的补充考虑.
研究的目的:
- 建议对集群头痛临床试验指南进行改进.
- 在试验设计中解决伦理考虑和招聘挑战.
主要方法:
- 引入非劣势性试验设计,以减轻与安慰剂相关的伦理问题.
- 讨论克服常见试验招聘障碍的战略.
主要成果:
- 非劣势性试验为集群头痛研究中的安慰剂对照研究提供了可行的替代方案.
- 解决招聘挑战可以提高试验结果的效率和通用性.
结论:
- 提出的方法提供了集群头痛试验设计的实际解决方案.
- 考虑这些问题将有助于成功实施新的指导方针,并推进集群头痛的研究.
- 进一步讨论试验方法对于推进集群头痛研究至关重要.
相关概念视频
01:12Hazard Ratio
121
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
121
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
01:11Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K